Back to User profile » Dr Mohammad Hassan Nazaran
Papers published by Dr Mohammad Hassan Nazaran:
GFc7 as a Smart Growth Nanofactor for ex vivo Expansion and Cryoprotection of Humans’ Hematopoietic Stem Cells
Hafizi M, Kalanaky S, Fakharzadeh S, Janzamin E, Arjmandi T, Atashi A, Nazaran MH
International Journal of Nanomedicine 2020, 15:6263-6277
Published Date: 21 August 2020
BCc1 Nanomedicine Therapeutic Effects in Streptozotocin and High-Fat Diet Induced Diabetic Kidney Disease
Fakharzadeh S, Argani H, Dadashzadeh S, Kalanaky S, Mohammadi Torbati P, Nazaran MH, Basiri A
Diabetes, Metabolic Syndrome and Obesity 2020, 13:1179-1188
Published Date: 17 April 2020
Effects of BCc1 nanoparticle and its mixture with doxorubicin on survival of murine 4T1 tumor model
Hafizi M, Soleimani M, Noorian S, Kalanaky S, Fakharzadeh S, Tavakolpoor Saleh N, Nazaran MH, Akbari ME
OncoTargets and Therapy 2019, 12:4691-4701
Published Date: 18 June 2019
DIBc, a nanochelating-based nano metal-organic framework, shows anti-diabetic effects in high-fat diet and streptozotocin-induced diabetic rats
Fakharzadeh S, Kalanaky S, Hafizi M, Nazaran MH, Zardooz H
International Journal of Nanomedicine 2019, 14:2145-2156
Published Date: 27 March 2019
BCc1, the novel antineoplastic nanocomplex, showed potent anticancer effects in vitro and in vivo
Kalanaky S, Hafizi M, Fakharzadeh S, Vasei M, Langroudi L, Janzamin E, Hashemi SM, Khayamzadeh M, Soleimani M, Akbari ME, Nazaran MH
Drug Design, Development and Therapy 2016, 10:59-70
Published Date: 30 December 2015
The therapeutic effects of MSc1 nanocomplex, synthesized by nanochelating technology, on experimental autoimmune encephalomyelitic C57/BL6 mice
Fakharzadeh S, Sahraian MA, Hafizi M, Kalanaky S, Masoumi Z, Mahdavi M, Kamalian N, Minagar A, Nazaran MH
International Journal of Nanomedicine 2014, 9:3841-3853
Published Date: 11 August 2014